| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 10/01/2008 | CN101274009A Compound formulation of capsules for curing lumbocrural pain and preparing technique |
| 10/01/2008 | CN101274008A Sustained-release dropping pill of Tripterygium glycosides and method of preparing the same |
| 10/01/2008 | CN101273998A Specific herbal medicine prescription for curing severe cold with multiple and complex symptoms |
| 10/01/2008 | CN101273789A Summer-heat clearing beverage and its preparing method |
| 10/01/2008 | CN100422186C Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 10/01/2008 | CN100422182C Imidazopyridine-derivatives as inducible NO-synthase inhibitors |
| 10/01/2008 | CN100422173C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 10/01/2008 | CN100422172C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 10/01/2008 | CN100422168C Hesperetin derivant and preparation process thereof |
| 10/01/2008 | CN100422160C Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives |
| 10/01/2008 | CN100421647C Topical anti-inflammatory compositions and methods of reducing inflammation |
| 10/01/2008 | CA2654898A1 New chemical compounds |
| 09/30/2008 | US7429609 Pyrazole compound and medicinal composition containing the same |
| 09/30/2008 | US7429591 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(2-Amino-6-chloro-phenyl)-piperazin-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 09/30/2008 | US7429588 Crystalline isoxazole derivative and medical preparation thereof |
| 09/30/2008 | US7429587 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 09/30/2008 | US7429578 e.g. phenyl-3,4-dihydropyrrolo[4,3,2-de]isoquinolin-5-(1H)-one; anticarcinogenic agent; stroke, head trauma, and neurodegenerative disease; potentiating cytotoxicity of a DNA-damaging cytotoxic agent or ionizing radiation |
| 09/30/2008 | US7429574 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use |
| 09/30/2008 | US7429562 Form a clear microemulsion upon contact with an aqueous medium; preconcentrates; reduced toxicity but high bioavailability; contain cyclosporin A analog ISATx247 (Voclosporin), tocopheryl polyethylene glycol 1000 succinate (Vitamin E TPGS), medium chain triglyceride (MCT) oil, emulsifier, and ethanol |
| 09/30/2008 | US7429384 Autoimmune diseases, graft rejections, chronic inflammations, sepsis, ischemia and reperfusion syndrome and atherosclerosis |
| 09/30/2008 | CA2626625A1 Intranasal drug delivery system |
| 09/30/2008 | CA2355470C Benzoheterocycles and their use as mek inhibitors |
| 09/30/2008 | CA2338220C Substituted imidazoles having cytokine inhibitory activity |
| 09/30/2008 | CA2313642C Pharmaceutical hydrogel formulations, drug delivery devices and methods |
| 09/25/2008 | WO2008116145A2 Soluble epoxide hydrolase inhibitors |
| 09/25/2008 | WO2008115413A1 Aromatase inhibitors for the treatment of mastalgia |
| 09/25/2008 | WO2008114819A1 Novel adenine compound |
| 09/25/2008 | WO2008114817A1 Novel adenine compound |
| 09/25/2008 | WO2008114812A1 Jak inhibitor |
| 09/25/2008 | WO2008114037A1 Treatment of inflammation and/or endotoxic shock |
| 09/25/2008 | WO2008114022A1 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents |
| 09/25/2008 | WO2008114002A1 Quinoline derivatives for the treatment of inflammatory diseases |
| 09/25/2008 | WO2008113881A1 Compound that is a dual inhibitor of enzymes pde7 and/or pde4, pharmaceutical compositions and uses thereof |
| 09/25/2008 | WO2008113863A2 Nitrosated derivatives of 2,5-dihydroxybenzene compounds |
| 09/25/2008 | WO2008113818A1 Use of quinoline derivatives in the treatment of pain and irritable bowel syndrome |
| 09/25/2008 | WO2008113500A1 Methods and compounds for modulating inflammatory processes |
| 09/25/2008 | WO2008096359A3 Agents for the treatment of multiple sclerosis and methods of using same |
| 09/25/2008 | WO2008093303A3 Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts |
| 09/25/2008 | WO2008084319A3 Novel nucleic acid |
| 09/25/2008 | WO2008062466A3 Cinnamic acid, vanillic acid and benzofuran derivatives for use in the treatment of inflammation and cancer |
| 09/25/2008 | US20080234467 Modifying amino acid sequences conjugate comprising: coupling N- alpha -protected amino acid to an immobilized peptide sequence, deprotecting sequence, cleaving peptide conjugate, recovering product |
| 09/25/2008 | US20080234380 Composition of 4-guanidinobenzoic acid HCl, a co-agent suitable for systemic administration solely via the oral route, antioxidants, vitamins, metabolites |
| 09/25/2008 | US20080234376 Prostaglandin E1, a phospholipid with a high purity and a non-proton-providing surfactant; hypertension, thrombosis, asthma, gastric and intestinal ulcers |
| 09/25/2008 | US20080234375 Process for Decreasing Environmental Pollutants in an Oil or a Fat, a Volatile Environmental Pollutants Decreasing Working Fluid, a Health Supplement, and an Animal Feed Product |
| 09/25/2008 | US20080234368 Therapeutic compositions and methods of use |
| 09/25/2008 | US20080234358 E-series of prostaglandin (EP) receptors; [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 09/25/2008 | US20080234347 Administering a hexahydrocycloheptapyrazole derivative, e.g., 8-(3-chloro-benzyl)-1,4,5,6,7,8-hexahydro-cycloheptapyrazole-3-carboxylic acid [(1S)-2-hydroxy-1-phenyl-ethyl]-amide; treating various kinds of pain including postoperative, inflammatory or neuropathic or the result of injury or age |
| 09/25/2008 | US20080234346 Pyrazalidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 09/25/2008 | US20080234345 Method for reducing or alleviating inflammation in the digestive tract |
| 09/25/2008 | US20080234335 2-Cyclohexenyl-1-carboxylic acid derivatives, e.g., 6-[2-(5-chloro-2-{[(4-fluorophenyl)methyl]oxy}phenyl)-1-cyclohexen-1-yl]-2-pyridinecarboxylic acid; treatment of conditions mediated by the action of PGE2 at EP1 receptors such as inflammatory pain, neuropathic pain or visceral pain |
| 09/25/2008 | US20080234324 Piperidine Derivatives as Gcs Inhibitors |
| 09/25/2008 | US20080234293 Tri-aryl/heteroaromatic cannabinoids and use thereof |
| 09/25/2008 | US20080234283 Glutathione peroxidase mimetics for treatment of neurodegenerative, pulmonary and inflammatory diseases |
| 09/25/2008 | US20080234271 Arylphenylamino- and Arylphenylether-Sulfide Derivatives, Useful For the Treatment of Inflammatory and Immune Diseases, and Pharmaceutical Compositions Containing Them |
| 09/25/2008 | US20080234266 Squaric Acid Derivatives II |
| 09/25/2008 | US20080234259 CB2 agonists; pain, neurodegenative disorders, eating disorders, weight loss or control, obesity, dyslipidemia, drug abuse, vision defect, neurodegenerative diseases; 5-(2,4-difluorophenyl)-4,5-diazatricyclo[5.2.1.0.sup.2,6.]deca-2-(6),3-dien-3-yl-phenylmethanone; antiinflammatory agent, antidepressant |
| 09/25/2008 | US20080234247 Heterocyclic analgesic compounds and methods of use thereof |
| 09/25/2008 | US20080234242 angiogenesis inhibitor; antiinflammatory agents; immunosuppressants; steroids conjugated compound |
| 09/25/2008 | US20080234214 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration |
| 09/25/2008 | US20080234211 Decladinosyl-Macrolides With Anti-Inflammatory Activity |
| 09/25/2008 | US20080234209 Derivatives of N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide; for preparation of drugs, gastrointestinal tract disease |
| 09/25/2008 | US20080234195 Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations |
| 09/25/2008 | US20080233187 Method of Production of Fine-Crystalline Mixture Containing Non-Steroid Anti-Inflammatory Drug, Fine-Crystalline Mixture Obtainable by this Method and Solid Pharmaceutical Composition Containing this Mixture |
| 09/25/2008 | US20080233163 4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenylamine; N-{4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenyl}-acetamide; or4-Methyl-5-(2-nitrooxy-ethyl)-2-(4-nitro-phenyl)-thiazole; cardiovascular, gastrointestinal, inflammatory, respiratory disease |
| 09/25/2008 | US20080233154 Immunoprotective and nontoxic Gram-negative bleb vaccine suitable for paediatric use; Neisseria meningitides; H. influenzae |
| 09/25/2008 | US20080233127 Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors |
| 09/25/2008 | US20080233115 Interleukins; cytokines; monoclonal antibodies; bioconjugation; toxic shock syndrome |
| 09/25/2008 | US20080233114 Antibodies to fibroblast growth factor; fusion proteins; cardiovascular disorders |
| 09/25/2008 | US20080233095 Method for obtaining antigen-specific tr1 regulatory lymphocytes |
| 09/25/2008 | US20080233078 Therapeutic polyesters and polyamides |
| 09/25/2008 | CA2684985A1 Combination of a narcotic and a non-narcotic analgesic |
| 09/25/2008 | CA2684382A1 Treatment of inflammation and/or endotoxic shock |
| 09/25/2008 | CA2682259A1 Compound that is a dual inhibitor of enzymes pde7 and/or pde4, pharmaceutical compositions and uses thereof |
| 09/25/2008 | CA2681501A1 Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors |
| 09/25/2008 | CA2681320A1 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents |
| 09/25/2008 | CA2680761A1 Quinoline derivatives for the treatment of inflammatory diseases |
| 09/25/2008 | CA2680708A1 Metal-binding therapeutic peptides |
| 09/25/2008 | CA2680397A1 Novel adenine compound |
| 09/24/2008 | EP1972631A1 Imidazopyridazines as PI3K lipid kinase inhibitors |
| 09/24/2008 | EP1971603A2 SULFOXIMINE DERIVATIVES AS p38 MAP KINASE INHIBITORS |
| 09/24/2008 | EP1971576A2 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 09/24/2008 | EP1971574A2 Bicyclic heterocyclic compounds as antiinflammatory or antiallergic agents |
| 09/24/2008 | EP1971369A2 Combination of anticholinergics, glucocorticoids, beta2-agonists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases |
| 09/24/2008 | EP1971230A2 Treatment of stressed patients |
| 09/24/2008 | EP1971227A2 High-potency sweetener composition with an anti-inflammatory agent and compositions sweetened therewith |
| 09/24/2008 | EP1601374B1 Compositions and methods for diagnosing and treating an inflammation |
| 09/24/2008 | EP1537096B1 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 09/24/2008 | EP1513520B1 Substituted pyrrolines as kinase inhibitors |
| 09/24/2008 | EP1509528B1 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/24/2008 | EP1465877B1 Positive-working photoimageable bottom antireflective coating |
| 09/24/2008 | EP1372617B1 Gastroresistant salts of ketoacids and amino acids and their use for preparing medicines |
| 09/24/2008 | EP1276462B1 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 09/24/2008 | CN201120000Y Traditional Chinese medicine permeation plaster |
| 09/24/2008 | CN101273059A Alpha-MSH analogue of therapeutic activity |
| 09/24/2008 | CN101273039A Heterobicyclic compounds useful as p38 kinase inhibiting agents |
| 09/24/2008 | CN101273035A Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/24/2008 | CN101273034A Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/24/2008 | CN101272783A (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor |
| 09/24/2008 | CN101272694A Novel milk protein fractions and use thereof for preventing or treating chronic inflammatory diseases |
| 09/24/2008 | CN101270102A Process for synthesizing parthenolide derivative and uses thereof |